Gymnema Sylvestre and Tirzepatide

Supplement–drug interaction evidence from the TruthStack database.

SeverityHIGH
Evidence TierModerate
Interaction TypePHARMACODYNAMIC RISK
MechanismPHARMACODYNAMIC
Last Reviewed2026-02-16

Summary

Gymnema sylvestre reduces intestinal glucose absorption and may stimulate insulin secretion. Combined with GLP-1 agonists, literature flags increased hypoglycemia risk. Discuss with your prescriber or pharmacist.

Higher-Concern Contexts

This interaction may be of particular concern in the following contexts:

API Reference

GET https://api.truthstack.co/v1/check?c1=Gymnema%20Sylvestre&c2=Tirzepatide

Open, unauthenticated. Returns JSON. Developer documentation

Related Interactions

Levothyroxine + Tirzepatide Calcium + Tirzepatide Fish Oil + Tirzepatide Folate + Tirzepatide Iron + Tirzepatide Magnesium + Tirzepatide Melatonin + Tirzepatide Gymnema Sylvestre + Semaglutide
What this page is and is not. TruthStack is an informational reference database that describes published pharmacological findings. It does not provide medical advice, diagnosis, or treatment recommendations. The information on this page reflects flags in our database and should not replace consultation with a qualified healthcare provider. Always discuss supplement-drug combinations with your prescriber or pharmacist.